{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:37Z","timestamp":1767135397715,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd001537.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"reference-count":93,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001537.pub4","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T20:11:33Z","timestamp":1202242293000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Interventions for minimal change disease in adults with nephrotic syndrome"],"prefix":"10.1002","author":[{"given":"Suetonia C","family":"Palmer","sequence":"first","affiliation":[{"name":"Brigham and Women's Hospital, Harvard Medical School; Renal Division; Harvard Institute of Medicine, Room 550 4 Blackfan Street Boston MA USA 02115"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kushma","family":"Nand","sequence":"additional","affiliation":[{"name":"Northshore Hospital; Renal\/General Medicine; Private Bag 93503 Takapuna North Shore New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"10.1002\/14651858.CD001537.pub4-BIB0001|cit1","first-page":"18","article-title":"Adult minimal change nephropathy: experience of the collaborative study of glomerular disease","volume":"97","author":"Coggins","year":"1985","journal-title":"Transactions of the American Clinical & Climatological Asoociation"},{"issue":"6505","key":"10.1002\/14651858.CD001537.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/bmj.291.6505.1305","article-title":"Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome","volume":"291","author":"Imbasciati","year":"1985","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1445-5994.1983.tb04479.x","article-title":"Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome","volume":"13","author":"Yeung","year":"1983","journal-title":"Australian & New Zealand Journal of Medicine"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD001537.pub4-BIB0004|cit4","first-page":"87","article-title":"Influence of protein contents of the diet and angiotensin converting inhibitors in the adult nephrotic syndrome. Randomized and crossed, prospective study","volume":"13","author":"Abaigar","year":"1993","journal-title":"Nefrologia"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"http:\/\/www.ijne","DOI":"10.4103\/0971-4065.34851","article-title":"Randomised controlled study of enalapril in steroid resistant nephrotic syndrome","volume":"12","author":"Arora","year":"2002","journal-title":"Indian Journal of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD001537.pub4-BIB0006|cit6","first-page":"A113","article-title":"Single versus divided dose prednisolone therapy for relapses of nephrotic syndrome (NS) [abstract]","volume":"12","author":"Bagga","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0007|cit7","unstructured":"Bagga A Hari P Srivastava RN Long (lp) versus standard (sp) initial prednisolone treatment for nephrotic syndrome (ns) [abstract] Nephrology, Urology, Transplantation Society of SAARC, Sri Lanka 1999 158"},{"issue":"9","key":"10.1002\/14651858.CD001537.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004670050708","article-title":"Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome","volume":"13","author":"Bagga","year":"1999","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1523-1755.1999.07002.x","article-title":"Management of minimal lesion glomerulonephritis: Evidence-based recommendations","volume":"55","author":"Bargman","year":"1999","journal-title":"Kidney International - Supplement"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001537.pub4-BIB0010|cit10","first-page":"65","article-title":"Effective and safe treatment of primary nephrotic syndrome with tacrolimus (FK 506) [abstract]","volume":"18","author":"Beige","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5720","key":"10.1002\/14651858.CD001537.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","article-title":"Controlled trial of prednisone in adult patients with the nephrotic syndrome","volume":"3","author":"Black","year":"1970","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0012|cit12","first-page":"414","article-title":"A randomised double blind study of deflazacort (d) versus prednisone (p) in the treatment of idiopathic nephrotic syndrome (ins) [abstract]","volume":"6","author":"Broyer","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular diseases","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1681\/ASN.V541047","article-title":"Cyclosporine for nephrotic syndrome--isn't it time for a collaborative trial?","volume":"5","author":"Cole","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1681\/ASN.V122341","article-title":"Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease","volume":"12","author":"Deighan","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD001537.pub4-BIB0016|cit16","first-page":"A88","article-title":"The comparison of antiproteinuric effects of angiotensin converting enzyme inhibitor enalapril and angiotensin ii receptor antagonist losartan in nephrotic syndrome cases [abstract]","volume":"14","author":"Dilek","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0017|cit17","first-page":"S163","article-title":"Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome","volume":"27","author":"Don","year":"1989","journal-title":"Kidney International - Supplement"},{"issue":"6","key":"10.1002\/14651858.CD001537.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/08860229509037637","article-title":"Long-term cyclosporin A treatment in adults with refractory nephrotic syndrome","volume":"17","author":"El-Reshaid","year":"1995","journal-title":"Renal Failure"},{"issue":"6","key":"10.1002\/14651858.CD001537.pub4-BIB0019|cit19","first-page":"315","article-title":"Treatment of proteinuric patients with a vegetarian soy diet and fish oil","volume":"40","author":"Gentile","year":"1993","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ki.1989.189","article-title":"Treatment of nephrotic hyperlipoproteinemia with gemfibrozil","volume":"36","author":"Groggel","year":"1989","journal-title":"Kidney International"},{"issue":"12","key":"10.1002\/14651858.CD001537.pub4-BIB0021|cit21","first-page":"963","article-title":"A double-blind trial of \"alternate-day\" steroid therapy in adult nephrotics - a preliminary report","volume":"18","author":"Gulati","year":"1970","journal-title":"Journal of the Association of Physicians of India"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0022|cit22","first-page":"266","article-title":"Alternate-day steroid therapy in adult nephrotics","volume":"4","author":"Gulati","year":"1973","journal-title":"Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0023|cit23","first-page":"301","article-title":"Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome","volume":"32","author":"Ishikawa","year":"1982","journal-title":"Arzneimittel-Forschung"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0024|cit24","first-page":"135","article-title":"The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method","volume":"21","author":"Ishikawa","year":"1979","journal-title":"Nippon Jinzo Gakkai Shi. Japanese Journal of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0025|cit25","first-page":"447","article-title":"Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults","volume":"44","author":"Koike","year":"2002","journal-title":"Nippon Jinzo Gakkai Shi. Japanese Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0026|cit26","first-page":"110","article-title":"Effect of Ace inhibitor and calcium channel blocker on proteinuria in subjects with steroid resistant idiopathic nephrotic syndrome [abstract]","volume":"11","author":"Kumar","year":"2001","journal-title":"Indian Journal of Nephrology"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0027|cit27","first-page":"454","article-title":"Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome","volume":"52","author":"Kumar","year":"2004","journal-title":"Journal of the Association of Physicians of India"},{"issue":"6","key":"10.1002\/14651858.CD001537.pub4-BIB0028|cit28","first-page":"375","article-title":"The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea","volume":"43","author":"Lee","year":"1995","journal-title":"Clinical Nephrology"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Leisti S Koskimies O Perheentupa J Vilska J Hallman N Idiopathic nephrotic syndrome: prevention of early relapse British Medical Journal 1978 892 346147","DOI":"10.1136\/bmj.1.6117.892"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/cs0770445","article-title":"Effect of a high protein diet in patients with the nephrotic syndrome","volume":"77","author":"Mansy","year":"1989","journal-title":"Clinical Science"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0031|cit31","first-page":"277","article-title":"Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome","volume":"41","author":"Martins","year":"1994","journal-title":"Clinical Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0032|cit32","first-page":"120","article-title":"A controlled clinical trial of Consupren versus cyclophosphamide in chronic glomerulonephritis","volume":"136","author":"Matl","year":"1997","journal-title":"Casopis Lekaru Ceskych"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0033|cit33","first-page":"120","article-title":"A controlled clinical study of Consupren versus Cyclophosphamide in chronic glomerulonephritis. I. Efficacy of therapy","volume":"136","author":"Matl","year":"1997","journal-title":"Casopis Lekaru Ceskych"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000049077","article-title":"Novel trial for the treatment of steroid dependency in minimal change disease: Combined therapy of camostat mesilate and glycyrrhizin","volume":"90","author":"Matsubara","year":"2002","journal-title":"Nephron"},{"issue":"8","key":"10.1002\/14651858.CD001537.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2169\/internalmedicine.43.668","article-title":"Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome","volume":"43","author":"Matsumoto","year":"2004","journal-title":"Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000013504","article-title":"Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patients with nephrotic syndrome","volume":"19","author":"Matzkies","year":"1999","journal-title":"American Journal of Nephrology"},{"issue":"3 Suppl 4","key":"10.1002\/14651858.CD001537.pub4-BIB0037|cit37","first-page":"259","article-title":"Treatment with cyclosporine of adult idiopathic nephrotic syndrome resistant to corticosteroid and other immunosuppressants","volume":"20","author":"Meyrier","year":"1988","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD001537.pub4-BIB0038|cit38","first-page":"S37","article-title":"Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology","volume":"35","author":"Meyrier","year":"1991","journal-title":"Clinical Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ki.1994.189","article-title":"Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie","volume":"45","author":"Meyrier","year":"1994","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/08860229609047706","article-title":"Use of cyclosporine A in the treatment of refractory nephrotic syndrome in adults","volume":"18","author":"Meyrier","year":"1996","journal-title":"Renal Failure"},{"issue":"9","key":"10.1002\/14651858.CD001537.pub4-BIB0041|cit41","first-page":"A74","article-title":"The effect of high dose methylprednisolone therapy in patients with minimal change nephrotic syndrome [abstract]","volume":"12","author":"Mocan","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001537.pub4-BIB0042|cit42","first-page":"S125","article-title":"A clinical study on low dose cyclosporin a with diltiazem in the treatment of primary nephrotic syndrome [abstract]","volume":"3","author":"Naigui","year":"1997","journal-title":"Nephrology"},{"issue":"Nov","key":"10.1002\/14651858.CD001537.pub4-BIB0043|cit43","first-page":"524A","article-title":"A controlled, prospective study of efficacy of leflunomide in patients with nephrotic syndrome [abstract]","volume":"14","author":"Ni","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.V541049","article-title":"Cyclosporine in the treatment of idiopathic nephrosis","volume":"5","author":"Niaudet","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1046\/j.1523-1755.1999.07128.x","article-title":"Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group","volume":"71","author":"Olbricht","year":"1999","journal-title":"Kidney International - Supplement"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001537.pub4-BIB0046|cit46","first-page":"63","article-title":"Therapy of first episode of steroid responsive nephrotic syndrome: a randomised controlled trial [abstract]","volume":"18","author":"Pecoraro","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0011-393X(05)80680-0","article-title":"Bioequivalence of deflazacort and prednisone in the treatment of idiopathic nephrotic syndrome. A pilot study","volume":"54","author":"Piccoli","year":"1993","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00044011-199816030-00005","article-title":"Immunosuppressive treatment for idiopathic syndrome with corticosteroids and cyclophosphamide. Factors associated with a favorable outcome","volume":"16","author":"Pirisi","year":"1998","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0050|cit49","first-page":"147","article-title":"A multicenter controlled prospective trial with cyclosporine vs cyclophosphamide in frequent relapsers and steroid dependent patients with idiopathic nephrotic syndrome","volume":"2","author":"Ponticelli","year":"1989","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0051|cit50","unstructured":"Ponticelli C Ciclosporin in the treatment of idiopathic nephrotic syndrome [abstract] 10th Asian Colloquium in Nephrology; 1994 Dec 2-6; Karachi (Pakistan) 1994 116"},{"issue":"12","key":"10.1002\/14651858.CD001537.pub4-BIB0049|cit51","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD001537.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney International"},{"issue":"8624","key":"10.1002\/14651858.CD001537.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(88)90870-7","article-title":"Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome","volume":"2","author":"Rabelink","year":"1988","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001537.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ndt\/14.1.91","article-title":"Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome","volume":"14","author":"Reichert","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5656","key":"10.1002\/14651858.CD001537.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/bmj.2.5656.535","article-title":"Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisone and azathioprine","volume":"2","author":"Sharpstone","year":"1969","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10157-004-0276-0","article-title":"A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)","volume":"8","author":"Shibasaki","year":"2004","journal-title":"Clinical & Experimental Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001537.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0272-6386(12)70180-4","article-title":"Treatment of hyperlipidemia in the nephrotic syndrome: the effects of pravastatin therapy","volume":"22","author":"Spitalewitz","year":"1993","journal-title":"American Journal of Kidney Diseases"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD001537.pub4-BIB0058|cit58","first-page":"126A","article-title":"Efficacy of levamisole compared to cyclophosphamide and steroid in frequently in frequently relapsing (FR) minimal change nephrotic syndrome (MCNS) [abstract]","volume":"12","author":"Sural","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3 Suppl 4","key":"10.1002\/14651858.CD001537.pub4-BIB0059|cit59","first-page":"262","article-title":"A randomized trial of cyclosporine with low-dose prednisone compared with high-dose prednisone in nephrotic syndrome","volume":"20","author":"Tejani","year":"1988","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ki.1993.358","article-title":"Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria","volume":"44","author":"Thomas","year":"1993","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD001537.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000013549","article-title":"Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome","volume":"20","author":"Toto","year":"2000","journal-title":"American Journal of Nephrology"},{"issue":"7763","key":"10.1002\/14651858.CD001537.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(72)90978-6","article-title":"Cyclophosphamide therapy in adults with minimal change nephrotic syndrome","volume":"1","author":"Uldall","year":"1972","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000415406","article-title":"Evaluation of prednisolone pulse therapy in steroid-resistant nephrotic syndrome. A multicenter collaborative study","volume":"67","author":"Wyszynska","year":"1988","journal-title":"Contributions to Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD001537.pub4-BIB0064|cit64","article-title":"Contrasting efficacy of two different treatment programs in adult frequently relapsing nephrotic syndrome [abstract]","volume":"4","author":"Ye","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000424282","article-title":"Long-term cyclosporin in steroid-dependent nephrotic syndrome","volume":"114","author":"Yoshikawa","year":"1995","journal-title":"Contributions to Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001537.pub4-BIB0066|cit66","first-page":"26","article-title":"Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis","volume":"11","author":"Al-Khader","year":"1979","journal-title":"Clinical Nephrology"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(61)91026-1","article-title":"164 children with nephrosis","volume":"II","author":"Arneil","year":"1961","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD001537.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ajkd.1998.v31.pm9469489","article-title":"Successful mycophenolate mofetil treatment of glomerular disease","volume":"31","author":"Briggs","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"issue":"11","key":"10.1002\/14651858.CD001537.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/ndt\/17.11.2011","article-title":"Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome","volume":"17","author":"Day","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6964","key":"10.1002\/14651858.CD001537.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0072|cit72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002290.pub2","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","author":"Durkan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7109","key":"10.1002\/14651858.CD001537.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0074|cit74","unstructured":"The European Vasculitis Study Group http:\/\/www.vasculitis.org (accessed November 2007)"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ndt\/18.2.245","article-title":"Recent approaches to the pathogenesis of minimal-change nephrotic syndrome","volume":"18","author":"Grimbert","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0272-6386(95)90437-9","article-title":"Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies","volume":"26","author":"Haas","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997","volume":"30","author":"Haas","year":"1997","journal-title":"American Journal of Kidney Diseases"},{"issue":"7414","key":"10.1002\/14651858.CD001537.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD001537.pub4-BIB0079|cit79","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003594.pub3","article-title":"Interventions for idiopathic steroid-resistant nephrotic syndrome in children","author":"Hodson","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0080|cit80","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001533.pub4","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hodson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0081|cit81","volume-title":"Comprehensive clinical nephrology","author":"Johnson","year":"2003"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0272-6386(96)90098-0","article-title":"The racial prevalence of glomerular lesions in nephrotic adults","volume":"27","author":"Korbet","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0083|cit83","unstructured":"Lefebvre C McDonald S Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia) 1996"},{"issue":"11","key":"10.1002\/14651858.CD001537.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","article-title":"Long-term outcome of adult-onset minimal-change nephropathy","volume":"11","author":"Mak","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD001537.pub4-BIB0085|cit85","unstructured":"United States Cochrane Center Master list of journals being searched http:\/\/apps1.jhsph.edu\/cochrane\/masterlist.asp (accessed May 2007)"},{"issue":"5-6","key":"10.1002\/14651858.CD001537.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000065276","article-title":"Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil","volume":"22","author":"Mogyorosi","year":"2002","journal-title":"American Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD001537.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","article-title":"Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome","volume":"39","author":"Nakayama","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001537.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: a long-term follow-up","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD001537.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ndt\/gfh752","article-title":"Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case report","volume":"20","author":"Patel","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD001537.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/ndt\/12.11.2433","article-title":"Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome","volume":"12","author":"Schweda","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD001537.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/ndt\/gfg134","article-title":"Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses","volume":"18","author":"Tse","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD001537.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP65393","article-title":"Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome","volume":"65","author":"Westhoff","year":"2006","journal-title":"Clinical Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001537.pub4-BIB0093|cit93","first-page":"430","article-title":"Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome","volume":"30","author":"Woo","year":"2001","journal-title":"Annals of the Academy of Medicine, Singapore"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001537.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001537.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T14:16:22Z","timestamp":1737900982000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001537.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":93,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001537.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}